SOLU-MEDROL

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug SOLU-MEDROL contains one active pharmaceutical ingredient (API):

1 Methylprednisolone UNII LEC9GKY20K - METHYLPREDNISOLONE SODIUM SUCCINATE

Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. Read about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOLU-MEDROL Powder for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB04	Methylprednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11739W, 5264C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718010072117, 522718010072217, 522718010072317, 522718010072417
Country: CA	Health Products and Food Branch	Identifier(s): 00030678, 00036137, 02367947, 02367955, 02367963, 02367971
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28620-10-08, 28622-10-08
Country: EE	Ravimiamet	Identifier(s): 1007378, 1009112, 1009134, 1009156, 1009178
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 119953, 390116, 475703, 498818
Country: FR	Base de données publique des médicaments	Identifier(s): 60626197, 69424357, 69618515, 69774343
Country: HK	Department of Health Drug Office	Identifier(s): 00456, 00466
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 138, 139, 8220, 8221
Country: JP	医薬品医療機器総合機構	Identifier(s): 2456400D1067, 2456400D2098, 2456400D3094, 2456400D4074
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004534, 1004535, 1004536, 1004537
Country: MT	Medicines Authority	Identifier(s): AA565/52201, AA565/52202
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 74986
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 20370, 26050, 26069, 388
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1128, 1137, 1138, 1139, 8783
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100061820, 100061837, 100061843, 100061850, 100247097, 100326336
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65885001
Country: SG	Health Sciences Authority	Identifier(s): 04683P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6530065H, 9243121, 9243122
Country: US	FDA, National Drug Code	Identifier(s): 0009-0003, 0009-0018, 0009-0039, 0009-0047, 0009-0698, 0009-0758, 0009-0850, 50090-0271, 51662-1263, 51662-1264, 51662-1483, 52584-039, 52584-047, 55154-3939, 55154-3940, 55154-3941, 55154-3944, 68071-1792, 70518-2023, 71872-7061
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/21.5.1/136, D/21.5.1/35, L/21.5.1/25, L/21.5.1/26